Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
3
×
avapritinib
blueprint medicines
clinical trials
deals
eli lilly
fda
genentech
investing
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
selpercatinib
thyroid cancer
biofourmis
biovotion
cancer
cancer drugs
capmatinib
chugai pharmaceutical
cstone pharmaceuticals
edbi
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
gaido health
gastrointestinal stromal tumors
hepatocellular carcinoma
What
approval
blueprint
cancer
drug
fda
medicines
ret
address
analytics
approves
biofourmis
candidate
carries
certain
currently
data
designed
devices
digital
employs
genetic
globally
hauls
help
latest
marketing
million
muscle
pact
pass
patients
raised
regulatory
review
roche
scale
signature
signatures
startup
targeted
Language
unset
3
×
Current search:
roche
×
photo
×
" san francisco top stories "
×
unset
×
boston
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact